Trial NCT03515707

View at ClinicalTrials.gov 
Org. Study IDs: 9784
Secondary IDs: 9784 NCI-2017-02069 P30CA015704 RG9217025

Last trial update was posted on 2021-02-01

MeSH Interventions

Busulfan Etoposide Etoposide phosphate Podophyllotoxin

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Neoplasm, Residual

Other Conditions

Acute Myeloid Leukemia Minimal Residual Disease Negativity

Stopping Reasons

PI recommended closure

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID